PAM
FOLD icon

PSquared Asset Management’s Amicus Therapeutics FOLD Stock Holding History

PSquared Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,101,228
Closed -$15.9M – 20
2026
Q1 		$15.9M Buy
1,101,228
+51,228
+5% +$734K 5.54% 8
2025
Q4 		$15M Buy
+1,050,000
New +$10.3M 6.99% 7

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

PSquared Asset Management's FOLD Position: Q2 2026 in Review

PSquared Asset Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 1,101,228 shares — an estimated $15.9M sold.

PSquared Asset Management first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $15.9M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • PSquared Asset Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • PSquared Asset Management sold 1,101,228 Amicus Therapeutics shares in Q2 2026, an estimated $15.9M.
  • PSquared Asset Management first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
  • PSquared Asset Management's Amicus Therapeutics position peaked at $15.9M in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on PSquared Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.